Abstract:As desirable contrast agents for magnetic resonance imaging (MRI), ultrasmall superparamagnetic iron oxides (USPIOs) are required to exhibit both low cytotoxicity and specific targetability besides superparamagnetism to achieve better imaging contrast at lower dose, and cladding with biocompatible polymers and modification with targeting ligands are considered to be the most effective strategies. In this study, novel dextran wrapped and peptide WSGPGVWGASVK (peptide-WSG) grafted USPIOs were meticulously prepared and systematically characterized. Firstly, dextran (Dex) cladded USPIOs (USPIOs@Dex) were synthesized with a well-designed co-precipitation procedure in which the biocompatible dextran played dual roles of grain inhibitor and cladding agent. After that, sodium citrate was applied to carboxylize the hydroxyls of the dextran molecules via an esterification reaction, and then tumor targeting peptide-WSG was grafted to the carboxyl groups by the EDC method. The XRD, TEM, and FTIR results showed that inverse spinel structure Fe3O4 crystallites were nucleated and grown in aqueous solution, and the catenulate dextran molecules gradually bound on their surface, meanwhile the growth of grains was inhibited. The size of original crystallite grains was about 7 nm, but the mean size of USPIOs@Dex aggregates was 165.20 nm. After surface modification by sodium citrate and peptide-WSG with ultrasonic agitation, the size of the USPIOs@Dex-WSG aggregates was smaller (66.06 nm) because the hydrophilicity was improved, so USPIOs@Dex-WSG could evade being eliminated by RES more easily, and prolong residence time in blood circulation. The VSM and T-2-weighted MRI results showed that USPIOs@Dex-WSG were superparamagnetic with a saturation magnetization of 44.65 emu g(-1), and with high transverse relaxivity as the R-2 relaxivity coefficient value was 229.70 mM(-1) s(-1). The results of MTT assays and the Prussian blue staining in vitro revealed that USPIOs@Dex-WSG exhibited nontoxicity for normal cells such as L929 and HUVECs, and were specifically targeted to the SKOV-3 cells. Thus, the novel dextran wrapped and WSG-peptide grafted USPIOs have potential to be applied as tumor active targeting contrast agents for MRI.

Synthesis and Properties of USPIO MRI Contrast

Ultrasmall superparamagnetic iron oxide nanoparticles for magnetic resonance imaging contrast agent.

Facile Synthesis Of Polymer-Enveloped Ultrasmall Superparamagnetic Iron Oxide For Magnetic Resonance Imaging

Preparation and Performance Study on Ultrasmall Superparamagnetic Iron Oxide(uspio) Nanoparticles

Ultrasmall Superparamagnetic Iron Oxide Nanoparticles: A Next Generation Contrast Agent for Magnetic Resonance Imaging

Ultrasmall Superparamagnetic Iron Oxide Nanoparticle for T2-Weighted Magnetic Resonance Imaging.

Synthesis and Application of Magnetic Iron Oxide Nanoparticles as High Efficiency Magnetic Resonance Imaging Contrast Agent

Superparamagnetic Iron Oxide Nanoparticles: from Preparations to in Vivo MRI Applications

Recent development in targeted MRI negative contrast based on ultra-small superparamagnetic iron oxide particles

Silica-coated Super-Paramagnetic Iron Oxide Nanoparticles (spionps): a New Type Contrast Agent of T1 Magnetic Resonance Imaging (MRI).

Ultrasmall Water-Soluble Metal-Iron Oxide Nanoparticles As T1-weighted Contrast Agents for Magnetic Resonance Imaging.

Precise Study on Size-Dependent Properties of Magnetic Iron Oxide Nanoparticles for in Vivo Magnetic Resonance Imaging

Preparation and characterization of peptide modified ultrasmall superparamagnetic iron oxides used as tumor targeting MRI contrast agent

Hydrothermal synthesis of a highly sensitive T2-weigthed MRI contrast agent: zinc-doped superparamagnetic iron oxide nanocrystals.

A T1/T2 dual functional iron oxide MRI contrast agent with super stability and low hypersensitivity benefited by ultrahigh carboxyl group density

Synthesis of sub-100 nm biocompatible superparamagnetic Fe3O4 colloidal nanocrystal clusters as contrast agents for magnetic resonance imaging

A Sub-50-nm Monosized Superparamagnetic Fe3O4@SiO2 T2-weighted MRI Contrast Agent: Highly Reproducible Synthesis of Uniform Single-Loaded Core-Shell Nanostructures.

Mn(ii) Chelate-Coated Superparamagnetic Iron Oxide Nanocrystals As High-Efficiency Magnetic Resonance Imaging Contrast Agents

One-pot Synthesis of Water-Soluble Superparamagnetic Iron Oxide Nanoparticles and Their MRI Contrast Effects in the Mouse Brains.

Synthesis and Characterization of PVP-coated Large Core Iron Oxide Nanoparticles As an MRI Contrast Agent.

Superparamagnetic nanoparticle-inclusion microbubbles for ultrasound contrast agents